Ensign Peak Advisors’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $56.8M | Sell |
|
|||||
|
2025
Q1 | $64M | Sell |
|
|||||
|
2024
Q4 | $54.2M | Buy |
|
|||||
|
2024
Q3 | $48M | Buy |
|
|||||
|
2024
Q2 | $41.7M | Buy |
|
|||||
|
2024
Q1 | $35.2M | Buy |
|
|||||
|
2023
Q4 | $30.1M | Buy |
|
|||||
|
2023
Q3 | $16.7M | Sell |
|
|||||
|
2023
Q2 | $18.6M | Hold |
|
|||||
|
2023
Q1 | $17.9M | Buy |
|
|||||
|
2022
Q4 | $6.28M | Buy |
|
|||||
|
2022
Q3 | $5.58M | Buy |
|
|||||
|
2022
Q2 | $4.45M | Buy |
|
|||||
|
2022
Q1 | $4.72M | Sell |
|
|||||
|
2021
Q4 | $7.88M | Sell |
|
|||||
|
2021
Q3 | $22.3M | Buy |
|
|||||
|
2021
Q2 | $23.4M | Buy |
|
|||||
|
2021
Q1 | $21.9M | Buy |
|
|||||
|
2020
Q4 | $12.8M | Sell |
|
|||||
|
2020
Q3 | $7.75M | Buy |
|
|||||
|
2020
Q2 | $4.86M | Buy |
|
|||||
|
2020
Q1 | $4.13M | Buy |
|
|||||
|
2019
Q4 | $3.87M | Buy |
|